この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2019/7/121 分で読めます
Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients; Public Workshop; Cancellation
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration is announcing the cancellation of a public workshop entitled "Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients" that was previously scheduled for August 8, 2019, from 8:30 a.m. to 4:30 p.m. This public workshop was announced in the Federal Register of May 2, 2019. The meeting has been cancelled due to unforeseen changes in the adenovirus drug development landscape.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →